Local interventional therapy brings more choices Xiangtan Central Hospital has opened a new journey of lung tumor treatment

Jiang Mingyan was instructed in surgery

Red Net Moment, January 26 (Correspondent Luo Yan Guo Kai) "Thank you, it feels good to be discharged from the hospital and go home for the New Year. Recently, suffering from lung squamous cell carcinoma, 71-year-old Grandma Song successfully completed bronchial artery perfusion chemotherapy + drug-carrying microsphere embolization in Xiangtan Central Hospital, with stable vital signs and recovery and discharge.

In August 2021, Grandma Song, a 71-year-old who was diagnosed with lung squamous cell carcinoma, found that lung cancer recurred, due to advanced age, the risk of surgery was greater, and she could only receive systemic chemotherapy, with severe bone marrow suppression chemotherapy side effects such as thrombocytopenia, and the tumor was still growing and progressing, and there was obvious dyspnea. Jiang Mingyan, director of the Department of Respiratory and Critical Care Medicine of Xiangtan Central Hospital, organized the department to discuss and analyze the case of Grandma Song, and after consideration, decided to formulate a double interventional treatment plan for her, first of all, Grandma Song was subjected to pulmonary vascular intervention surgery - bronchial artery perfusion chemotherapy + drug-loading microsphere embolization, blocking the blood vessels and "starving" tumors, and also for follow-up bronchoscopic intervention to reduce the risk of intraoperative bleeding. Then there is bronchoscopic interventional surgery - cryohear electrocoagulation tumor surgery, opening the right bronchi, and if necessary, radioactive particles can be implanted with internal radiotherapy to achieve the purpose of reducing or eliminating tumors and pating the airway.

After Jiang Mingyan communicated the diagnosis and treatment plan with the patient and his family, Grandma Song's family expressed their willingness to actively cooperate with the treatment. On the morning of January 15th, the Department of Respiratory and Critical Care Medicine performed pulmonary vascular intervention surgery for Grandma Song, and The deputy director of the department, Song Chengfeng, chief physician of the department, and Guo Kai, under the guidance of Professor Zhu Ziyang, chief surgeon of the Pulmonary Vascular Intervention Diagnosis and Treatment Center of Jianghan University Affiliated Hospital, successfully completed bronchial artery perfusion chemotherapy + drug-loading microsphere embolization. On January 17, tracheoscopic interventional surgery was completed. After the operation, Grandma Song's vital signs were stable and she was discharged from the hospital a few days ago.

Coincidentally, the 57-year-old Uncle Zhou was admitted to the hospital for hemoptysis, and finally diagnosed with advanced lung squamous cell carcinoma after diagnosis and treatment by the respiratory and critical care medical department, he also encountered a treatment "bottleneck" and stood at the fork in the road of choice. In view of the condition, Jiang Mingyan judged that there were also indications for pulmonary vascular intervention, and on the afternoon of January 15, the pulmonary vascular intervention team opened the stage continuously and successfully completed another bronchial artery perfusion chemotherapy + drug-loading microsphere embolization.

Most lung cancer patients, through their understanding of pulmonary vascular intervention, tend to regain confidence in treatment and are willing to accept interventional treatment for local tumors. Studies have shown that bronchial artery perfusion chemotherapy combined with embolic chemotherapy has a significant effect on lung cancer patients, with higher treatment safety and fewer adverse reactions, which means that it will bring more treatment options to tumor patients and bring good news to more families. The Department of Respiratory and Critical Care Medicine of Xiangtan Central Hospital will go all out to arm itself with the latest theory and practical technology, and work together to create a safe and effective high-quality diagnosis and treatment team that can defeat lung cancer, and serve the citizens of Xiangtan wholeheartedly.